Skip to main content
CDC Website

Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)

The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Funding ID:
RFA-DA-25-012
Application Due Date:
Application Contact
Shang-Yi Anne
Tsai, Ph.D.
Scientific/ Research Contact- NIDA
United States
3018275842
stsai@nih.gov
Technical Contact
Ericka
Wells
Financial/Grants Management Contact, NIDA
United States
3018276705
wellse2@nida.nih.gov
Funding Organization:
The US Department of Health and Human Services National Institutes of Health
  • HIV/AIDS
  • Other Health-Related
  • International
  • Clinical Research
  • Data Analysis
  • HIV
  • HIV and AIDS Prevention
  • Research
Was this page helpful? Give Feedback